Skip to content
Question
Can I get it prescribed?
What it costs
$189.58/mo
Read
7 min
Updated
November 2026

Sermorelin vs Ipamorelin: One Has a Price, the Other Has No Lawful Route

Sermorelin is compoundable because it is a component of an approved drug. Ipamorelin acetate sits in FDA's 503B Category 2 for significant safety risks and appears on no 503A list, so it has no price here at all.

ByJenna PrattConsumer-access reporterPublished Updated

These two peptides are shopped for together and cannot be bought the same way. A month of sermorelin runs a typical $189.58 across 151 sellers that publish a figure, and ipamorelin appears on no FDA list that opens a compounded route. That difference is not a matter of which is more popular or better studied. It comes down to two separate places in federal law, and they say opposite things.

What each of the two can be bought for, November 2026
SermorelinIpamorelin
Sellers publishing a monthly price1510
Lowest published month$90No published market
Typical (median) month$189.58No published market
Highest published month$449No published market
Sellers naming it in their own listingsSee the price board23
Named on a federal compounding list503B Category 1, as an approved drug's component503B Category 2, significant safety risks
What each of the two can be bought for, November 2026. Sermorelin figures are computed from every tracked seller that publishes a monthly injection price, each counted once at its lowest month. Ipamorelin is research-only here, so no price is published for it whatever a seller advertises.

Why sermorelin can be compounded

Federal law lets a pharmacy compound from a bulk substance in three cases, and one of them is a substance that is a component of a drug the agency has approved[1].

Sermorelin qualifies through GEREF, which was approved as an injection under two applications and discontinued by its holder in 2008. In a notice published March 4, 2013, FDA determined that GEREF had not been withdrawn from sale for reasons of safety or effectiveness[2].

What that permits, and what it does not, is set out in is sermorelin FDA approved on this site. The outsourcing-facility list says the same thing in its own notation. “Sermorelin Acetate” sits in 503B Category 1 carrying the double asterisk that list uses to designate bulk drug substances that are components of FDA-approved drugs[3].

Why ipamorelin cannot

Ipamorelin is on the other list, by name. “Ipamorelin Acetate” appears in 503B Category 2, the group FDA describes as bulk drug substances that raise significant safety risks[3].

FDA gives its reason on the page that accompanies that category. Compounded drugs containing ipamorelin acetate may pose a risk of immunogenicity for certain routes of administration, because of the potential for aggregation or peptide-related impurities[4].

The agency adds two more points. Ipamorelin acetate contains unnatural amino acids, which add to the complexity of characterizing it, and a study published in the literature identified serious adverse events including death when ipamorelin was given intravenously to improve gastric motility[4].

For certain other injected routes, FDA says it has not identified safety-related information and therefore lacks enough information to know whether the drug would cause harm[4].

The 503A list is the pharmacy-side door, and ipamorelin is absent from all three of its categories in the May 14, 2026 update[5]. Neither FDA list opens a door for it, and are peptides legal covers which peptides have a lawful route at all. On October 30, 2026, HHS published a draft interim policy. It does not intend to act against 503A compounding with the peptides in its appendix during rulemaking[8]. The notice does not name those peptides, and the policy is not binding.

What has actually been measured in people

Ipamorelin has been through a controlled trial in patients, which is more than most peptides sold this way can claim. It did not work.

A phase 2, multicenter, double-blind, placebo-controlled study enrolled 117 adults having small or large bowel resection, of whom 114 made up the safety and modified intent-to-treat populations[6].

Participants received intravenous infusions of 0.03 mg/kg ipamorelin or placebo twice daily, from the first postoperative day for up to seven days or until discharge[6].

Median time to the first tolerated solid meal was 25.3 hours with ipamorelin against 32.6 hours with placebo, a difference the authors reported at p = 0.15[6]. Their conclusion was that there were no significant differences on the key or secondary efficacy analyses[6].

A 2026 review of approved and unapproved peptides marketed direct to patients covers both ipamorelin and sermorelin, alongside CJC-1295, BPC-157 and TB-500[7]. It says rigorous human safety data are scarce for many of the unapproved ones[7].

What this means for a quote in front of you

Two pages cover the sermorelin side: sermorelin prescription for the visit and the steps around it, and sermorelin tablets for the form comparison. The RUO peptides article explains what “research use only” and “compounded” each mean on a checkout page, and the Bodybuilding Health+ review records a sermorelin seller that lists no research-only compound. A menu that prices sermorelin and ipamorelin side by side is pricing one product that a pharmacy may lawfully make and one that it may not.

The two menu figures are not alternatives to each other, whatever the layout suggests.

FAQ

5 questions

Is ipamorelin cheaper than sermorelin?

There is no lawful compounded ipamorelin market to compare, so no honest price comparison exists. Sermorelin is priced by many sellers, and those figures are computed here from every one that publishes a monthly injection price.

Why can a pharmacy compound sermorelin but not ipamorelin?

Sermorelin acetate is a component of an approved drug, GEREF, which federal law treats as a qualifying bulk substance, and the 503B list marks it as such. Ipamorelin acetate is in 503B Category 2 for substances that raise significant safety risks and is named on no 503A list.

What safety concerns has FDA named about ipamorelin?

FDA cites a risk of immunogenicity for certain routes from aggregation or peptide-related impurities, unnatural amino acids that complicate characterization, and a published study identifying serious adverse events including death when ipamorelin was given intravenously for gastric motility.

Has ipamorelin been tested in a clinical trial?

Yes. A phase 2 double-blind placebo-controlled trial in 117 bowel resection patients gave 0.03 mg/kg intravenously twice daily for up to seven days. Median time to a first tolerated meal was 25.3 hours against 32.6 hours on placebo, reported at p = 0.15, and the authors found no significant differences on the efficacy analyses.

Why do sellers still list ipamorelin?

A listing on a seller's menu is not evidence that a lawful route exists. Those listings are recorded here as facts about the seller, and none of them can be priced, ranked or linked, because the compound register gates every figure on whether a compounding route exists.

Sources

8 cited
  1. [1]United States Code (2024). 21 U.S.C. 353a, Pharmacy compounding U.S. Government Publishing Office, govinfo. Source
  2. [2]Food and Drug Administration (2013). Determination That GEREF (Sermorelin Acetate) Injection, 0.5 Milligrams Base/Vial and 1.0 Milligrams Base/Vial, and GEREF (Sermorelin Acetate) Injection, 0.05 Milligrams Base/Amp, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness Federal Register, 78 FR 14095. Source
  3. [3]Food and Drug Administration (2025). Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act (updated March 21, 2025) U.S. Food and Drug Administration. Source
  4. [4]Food and Drug Administration (2026). Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks U.S. Food and Drug Administration. Source
  5. [5]Food and Drug Administration (2026). Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026) U.S. Food and Drug Administration. Source
  6. [6]Beck DE, Sweeney WB, McCarter MD (2014). Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients International Journal of Colorectal Disease. PMID 25331030
  7. [7]Mendias CL, Awan TM (2026). Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance Sports Medicine. PMID 41966639
  8. [8]Department of Health and Human Services (2026). Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances (draft; notice of availability) Federal Register, 91 FR 68526. Source

Where to buy Sermorelin

Lowest injection prices
  1. 1Contour HealthOur review$90/moGet price →
  2. 2Alternate Health ClubOur review$99/moGet price →
  3. 3Bayan HealthOur review$99/moGet price →

Medication price as each seller publishes it, before fees. The full Sermorelin price board